Tag Archive for: biotech

Cheaper versions of one of the most costly and widely used arthritis treatments in the U.S. are likely to fuel further scrutiny of the middlemen that negotiate drug prices for most insured Americans from lawmakers and the federal government, according to healthcare experts.

Next-gen biomanufacturers are particularly susceptible to the challenges inherent in manufacturing cell and gene therapies, risking getting derailed by unexpected costs for already-tight budgets.

Regulators have recently increased scrutiny on high-value deals.

“Fewer new funds (are) being raised and so we have the opportunity and the advantage of being able to start companies and support our current companies with a tremendous amount of capital,” said Dr. Beth Seidenberg, founding managing director at Westlake Village.

Despite a chilling economy, at least seven biotechs and biopharmas have posted sizable IPOs in 2023. Compared with last year, however, it’s clear that the industry is still in an IPO drought.

Recursion, which has partnered with drugmakers such as Bayer and Roche, plans to use Nvidia’s software to support its own pipeline as well as current and future partners.

The biotech will supply Canada with fewer doses of its coronavirus vaccine while reaching a financial agreement for the forfeiting of certain doses previously scheduled for delivery.

More than $5 billion poured into the longevity space in 2022, and experts say the science is now primed to make a real difference in extending human healthspan.

AstraZeneca inked a non-exclusive licensing agreement with Revvity for access to the Massachusetts biotech’s proprietary gene editing technology to develop cell therapies for cancer and immune-mediated conditions, Revvity announced Thursday.

The former chief financial officer of a New Jersey biotechnology company pleaded guilty on Wednesday to insider trading, after prosecutors said he had given nonpublic information about a new breast cancer drug to his girlfriend at the time.